- Khiron Life Sciences press release ( OTCQX:KHRNF ): Q2 GAAP EPS of -C$0.01.
- Revenue of C$4.47M (+59.6% Y/Y).
- Adjusted EBITDA -C$2.3M
For further details see:
Khiron Life Sciences GAAP EPS of -C$0.01, revenue of C$4.47Mhome / stock / khrnf / khrnf news
For further details see:
Khiron Life Sciences GAAP EPS of -C$0.01, revenue of C$4.47MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Khiron Life Sciences Corp Company Name:
KHRNF Stock Symbol:
Market:
Khiron Life Sciences Corp Website:
Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (" Khiron " or the " Company ") is pleased to announce that the Company has completed the sale of its European subsidiaries, being Khiron Europe GmbH (" Khiron Europe "), Zerenia C...
Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) (" Khiron " or the " Company ") today announced that the Company and 2518542 Alberta Ltd., a company controlled by Avonlea Drewry Holdings Inc. (the " Purchaser "), have entered into...
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (" Khiron " or the " Company ") announced today that the Company has agreed to a $500,000 non-interesting bearing refundable deposit from 2518542 Alberta Ltd. (" 251 "), a company co...